Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
BriaCell Therapeutics Announces Proposed Public Offering $BCTX https://t.co/kI6HSCUJT3
$CGEM with a ~$100M EV (>$600M in cash) while being literally the only CD19 TCE in US human clinical trials right now watching other companies say they would have to pay $600-$700M to get their hands on a CD19 TCE https://t.co/c6WtrJQdsx https://t.co/rZenhizy93
CG Oncology announces plans to conduct a public offering, with no specific details disclosed at this time. Stay tuned for updates. #CGOncology #PublicOffering #HealthcareNews
CG Oncology has announced plans for a proposed public offering, although specific details regarding the offering have not been disclosed. The announcement was made on December 11, 2024, and is part of the company's ongoing efforts to raise capital. In a related development, BriaCell Therapeutics also announced a proposed public offering on the same day. The announcements highlight a trend in the healthcare sector where companies are seeking to bolster their financial positions through public offerings.
